Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 16 Mar 23 EFFECT Notice of effectiveness
- 10 Mar 23 POS AM Prospectus update (post-effective amendment)
-
26 Mar 21 F-3ASR Automatic shelf registration (foreign)
Glaxosmithkline Capital similar filings
Filing view
External links
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form F-3 of our reports dated 12 March 2021 relating to the financial statements of GlaxoSmithKline plc and the effectiveness of GlaxoSmithKline plc’s internal control over financial reporting, appearing in the Annual Report on Form 20-F of GlaxoSmithKline plc for the year ended 31 December 2020. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ Deloitte LLP
London, United Kingdom
26 March 2021